Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial.
Product Packaging
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
Principal Investigator
Co-Investigator
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Co-Investigator
Overview
researcher role of
VanWagoner, Timothy
contributes to
Stephenson Cancer Center - Cancer Center Support Grant